Arcadia Biosciences Inc (NASDAQ:RKDA) CEO Raj Ketkar and CFO Matt Plavan tells Proactive Investors that the company is transitioning to a new health and nutrition business model from an old R&D-focused business.
Ketkar says first sales of its GoodWheat product combined and advancing its cannabis business should contribute to greater revenue growth into 2020.
Price: 3.72 USD
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...
In exchange for publishing services rendered by the Company on behalf of Arcadia Biosciences Inc named herein, including the promotion by the Company of Arcadia Biosciences Inc in any Content on the Site, the Company...
FOR OUR FULL DISCLAIMER CLICK HERE
Arcadia Biosciences Inc (NASDAQ:RKDA) CEO Matt Plavan tells Proactive that the agricultural technology company has raised about $6.8 million by selling warrants. Plavan says the company expects to use the proceeds to pursue a range of near-term inorganic growth opportunities within its hemp...
Director Interviews
Full interview: Arcadia Biosciences expecting dramatic growth in...
Director Interviews
Full interview: Arcadia Biosciences CEO highlights GoodHemp and...
Retail & consumer
Health
Prev article
